We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01263951
Recruitment Status : Active, not recruiting
First Posted : December 21, 2010
Last Update Posted : October 26, 2021
Sponsor:
Collaborators:
Bayer
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Thomas Jefferson University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 1, 2021
Estimated Study Completion Date : May 2022